These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10443962)

  • 1. Hereditary defects in fibrinolysis associated with thrombosis.
    Hong JJ; Kwaan HC
    Semin Thromb Hemost; 1999; 25(3):321-31. PubMed ID: 10443962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
    Kołodziejczyk J; Wachowicz B
    Pol Merkur Lekarski; 2009 Oct; 27(160):341-5. PubMed ID: 19928667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of research into the physiology and pathophysiology of the fibrinolysis system].
    Andreenko GV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1985; (10):5-19. PubMed ID: 2933082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The fibrinolytic system and its activators].
    Seifried E
    Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The fibrinolysis system in recurrent myocardial infarction].
    Panchenko VM; Serebriakova TN; Podorol'skaia LV; Zhivoderov VM; Andreenko GV
    Sov Med; 1991; (3):3-5. PubMed ID: 1831932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen activation: biochemistry, physiology, and therapeutics.
    Wun TC
    Crit Rev Biotechnol; 1988; 8(2):131-48. PubMed ID: 2976309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasminogen activation and regulation of fibrinolysis].
    Madoiwa S
    Nihon Rinsho; 2014 Jul; 72(7):1218-23. PubMed ID: 25163311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis and the risk of venous and arterial thrombosis.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
    Idell S
    Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in clinical fibrinolysis.
    Hessel LW; Kluft C
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
    Seth D; Hogg PJ; Gorrell MD; McCaughan GW; Haber PS
    J Hepatol; 2008 Apr; 48(4):614-27. PubMed ID: 18289715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological consequences of loss of plasminogen activator gene function in mice.
    Carmeliet P; Schoonjans L; Kieckens L; Ream B; Degen J; Bronson R; De Vos R; van den Oord JJ; Collen D; Mulligan RC
    Nature; 1994 Mar; 368(6470):419-24. PubMed ID: 8133887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis inhibitors.
    Davis GL
    Clin Lab Sci; 1997; 10(4):212-8. PubMed ID: 10169620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
    Humphries SE; Lane A; Dawson S; Green FR
    Arch Pathol Lab Med; 1992 Dec; 116(12):1322-9. PubMed ID: 1456879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.